Sale!

Tolterodine

A$0.00

-17%
Tolterodine is a medicine used to treat symptoms of an overactive bladder, such as needing to urinate urgently or frequently, or accidental leakage of urine. It works by relaxing the muscles of the bladder to help control urination. Tolterodine is usually taken by mouth, as directed by your doctor. Always follow your doctor's instructions and let them know about any side effects or concerns while taking this medication.

Tolterodine: Patient Information for Australia

Tolterodine is a prescription medicine used to treat symptoms of overactive bladder, such as urinary urgency, frequency, and leakage. It helps improve quality of life for people experiencing troublesome bladder symptoms.

Basic Product Information

International Non-proprietary Name (INN) Tolterodine
Australia Brand Names Detrusitol® (by Pfizer), Detrusitol SR®
ATC Code G04BD07
Available Forms & Strengths Tablets (1 mg, 2 mg), prolonged-release capsules (4 mg)
Main Manufacturers Pfizer Australia Pty Ltd, various generics
Prescription Status Schedule 4 (Prescription Only Medicine, Rx) in Australia

For up-to-date information, consult your pharmacist or general practitioner.

Mechanism of Action

  • Simplified: Tolterodine works by blocking specific receptors (called muscarinic receptors) on the bladder. This helps relax bladder muscles, reducing urgency and frequent urination.
  • For Healthcare Professionals: Tolterodine is a competitive muscarinic receptor antagonist that preferentially inhibits M2 and M3 subtypes on detrusor muscle, decreasing involuntary bladder contractions while maintaining relatively selective action on the bladder over salivary or other tissue receptors.

Pharmacokinetics

  • Absorption: After oral administration, Tolterodine is well absorbed, with peak blood levels (Tmax) reached in about 1–2 hours (immediate-release) or 2–6 hours (extended-release).
  • Metabolism: Metabolised primarily by the liver (CYP2D6 and CYP3A4 enzymes), forming active and inactive metabolites. The most active metabolite is 5-hydroxymethyl tolterodine.
  • Elimination: Mainly excreted in urine as metabolites; terminal half-life is about 2–3 hours (immediate-release) or up to 10–12 hours (extended-release).
  • Duration of Action: Once-daily extended-release formulations provide effects lasting 24 hours.

Use in Everyday Life and Best Practices

Tolterodine is commonly prescribed for people with overactive bladder (OAB) symptoms such as sudden urge to urinate, frequent urination, and incontinence. It is not typically used for stress incontinence. In Australia, your GP or specialist will advise the best formulation, taking into account your condition, lifestyle, and any other medicines you take.

  • Typical doses: Adults usually start with 2 mg tablets twice daily or 4 mg sustained-release capsules once daily. Dose adjustments may be needed for elderly patients, those with liver or kidney problems, or those experiencing side effects.
  • How to use: Swallow tablets/capsules whole with water. Do not crush or chew, especially the extended-release form.
  • Consistency is key: Take at the same time(s) each day to establish a routine and maximize benefits.
  • Always follow your doctor’s dosing instructions and seek advice before making changes.

Dosing in the Morning vs Evening

  • Morning dosing: May help avoid nighttime side effects (such as dry mouth) and fit better with daytime urine control needs for some patients.
  • Evening dosing: May reduce nocturia (frequent night urination) for some, but could increase sleep disruption due to dry mouth or other side effects.
  • Patient tip: Try to take your dose at the same time each day, and consult your healthcare provider if you wish to change timing.

Taking with Food or on an Empty Stomach

  • Tolterodine can be taken with or without food. Food has minimal effect on absorption for both immediate- and extended-release formulations.
  • For people with sensitive stomachs or on medications that irritate the stomach, taking Tolterodine with food may help reduce mild stomach upset.
  • There are no specific restrictions for timing with English or typical Australian diets.

Interaction Warnings

Type What to Watch For Advice
Food No major known interactions May be taken with food or on an empty stomach
Alcohol May worsen drowsiness or dry mouth; alcohol can exacerbate side effects Limit alcohol while taking Tolterodine
Medications CYP3A4 inhibitors (e.g., clarithromycin, ketoconazole) may increase blood Tolterodine
CYP2D6 inhibitors (e.g., fluoxetine, paroxetine) may also increase effect
Other anticholinergics (e.g., oxybutynin, amitriptyline) can increase side effects
Inform your prescriber and pharmacist about all medicines you take
Herbal remedies St John’s Wort may reduce effectiveness Avoid combining unless cleared by your doctor
Grapefruit juice Can increase blood levels in rare cases Best to avoid regular grapefruit juice consumption with Tolterodine

Indications

Indication Status Notes
Overactive bladder (OAB) with symptoms of urge incontinence, urgency, and frequency Approved Main and most common indication
Neurogenic detrusor overactivity Off-label in some cases When anticholinergic therapy is indicated and other therapies fail or are not tolerated
Paediatric use in neurogenic bladder dysfunction Unlicensed/off-label To be decided by specialist only; limited evidence

Dosing According to Indication and Patient Group

Patient Group Initial Dose Typical Dose Special Considerations
Adults 2 mg twice daily (IR) / 4 mg once daily (ER) As above May reduce to 1 mg twice daily if side effects
Elderly (65+ years) 1 mg twice daily (IR) / 2 mg once daily (ER) May increase if tolerated Monitor for adverse effects closely
Hepatic/renal impairment 1 mg twice daily (IR) / 2 mg once daily (ER, if used) Lowest effective dose Use with caution; specialist advice recommended
Children Not generally recommended in Australia Use only under specialist paediatrician guidance, off-label Insufficient evidence for routine use; consult urologist

Safety Profile and Side Effects

Like all medicines, Tolterodine may cause side effects. Report any side effects to your doctor or pharmacist, especially if severe or persistent.

Frequency Side Effect Notes
Very common (>10%) Dry mouth Most frequently reported; sugar-free chewing gum or water may help
Common (1–10%) Headache, constipation, abdominal pain, dry eyes, blurred vision, tiredness Usually mild and decrease with time
Uncommon (0.1–1%) Dizziness, allergic reactions, urinary tract infection, palpitations Seek medical attention if severe
Rare (<0.1%) Difficulty urinating, confusion (mainly in elderly), hallucinations, tachycardia, severe allergic reaction Stop medicine and contact emergency services if severe
  • Warnings: Tolterodine should be used with caution in people with angle-closure glaucoma, myasthenia gravis, severe liver or kidney impairment, and those at risk of urinary retention.
  • Monitor for confusion in elderly, especially in those with pre-existing cognitive impairment.

Guidelines for Proper Use (Australia)

  • Always collect your prescription from a registered Australian pharmacy.
  • Keep medicine in the original packaging, stored below 25°C, away from moisture and direct sunlight.
  • Do not share your medicine with anyone—even with similar symptoms.
  • If you miss a dose, take it as soon as you remember unless it is nearly time for your next dose—do not double up.
  • Combine medicine use with non-drug management (e.g., bladder training, pelvic floor exercises) for best results (see Continence Foundation of Australia for more information).
  • See your doctor or pharmacist if you experience troublesome side effects or no improvement after several weeks.

Alternative Treatment Options

  • Oxybutynin: Also anticholinergic; can be effective but has higher rates of dry mouth and cognitive effects, especially in elderly. Available as tablets, oral liquid, or patch.
  • Solifenacin, Darifenacin, Fesoterodine: Newer antimuscarinics with similar efficacy; may have different side effect profiles. Some are government-reimbursed (PBS) for certain indications.
  • Mirabegron: Works differently (beta-3 agonist); less risk of dry mouth, but can raise blood pressure. PBS listed for overactive bladder and a good option if intolerant to anticholinergics.
  • Non-medicine options: Bladder training, pelvic floor physiotherapy, regular fluid management, and scheduled toilet times. First-line for many patients.

Discuss all options with your doctor, especially if you have other health conditions or are taking multiple medicines.

Legal, Registration, and Reimbursement Status in Australia

  • Regulatory Authority: Registered with the Therapeutic Goods Administration (TGA).
  • Legal status: Prescription only (Schedule 4). Must be prescribed by your Australian GP or specialist.
  • Reimbursement: Listed on the Pharmaceutical Benefits Scheme (PBS) for certain patients with symptoms of OAB, reducing out-of-pocket costs.
  • Generic options may be available and reimbursed under the PBS.

Latest Research and Clinical Guidance (2022–2025)

  • Current English and European guidelines (NICE 2022, EAU 2023) recommend Tolterodine as a first-line pharmacological therapy for overactive bladder when lifestyle and physiotherapy interventions are insufficient (see NICE NG123).
  • Recent studies suggest that extended-release Tolterodine is generally as effective as oxybutynin but causes less dry mouth and is better tolerated (Chapple et al., Therapeutic Advances in Urology, 2022).
  • No new major safety warnings have been issued, but caution is still advised in older adults due to risk of cognitive effects.
  • Australian clinical practice recommends regular review after 4–8 weeks to assess efficacy, side effects, and consider deprescribing or alternatives where appropriate.

Availability and Delivery

Pack Size Usual Contents Indicative PBS Price* Typical Delivery Estimate (Business Days)
30 tablets (1 mg or 2 mg) 1 month’s supply $30–$40 (varies with PBS/concession)
  • Sydney: 1–2 days
  • Melbourne: 1–3 days
  • Brisbane: 1–2 days
  • Perth: 2–5 days
  • Adelaide: 1–3 days
  • Regional/rural: 2–7 days
30 prolonged-release capsules (4 mg) 1 month’s supply $35–$45 (varies with PBS/concession) As above

*Prices correct as of June 2024 — may vary by pharmacy and concessional status.

Frequently Asked Questions (FAQ)

  • How long will it take for Tolterodine to work?
    Most people start to notice an effect within 1–2 weeks, but it may take up to 4–8 weeks to achieve the full benefit.
  • Is it safe to take Tolterodine for a long time?
    For most adults, long-term use is safe if monitored regularly. Your doctor should review your need for the medicine every 6–12 months, especially if you are over 65.
  • What if I forget a dose?
    Take it as soon as you remember, unless it is nearly time for your next scheduled dose. Do not double up on doses.
  • Can I drink alcohol while on Tolterodine?
    Moderate alcohol is unlikely to cause severe problems, but it can worsen side effects like drowsiness or dry mouth. It is best to limit alcohol while on this medication.
  • Will Tolterodine cure my overactive bladder?
    Tolterodine controls symptoms but does not cure the condition. Most people use it long-term along with lifestyle changes and bladder training.

Always consult your pharmacist or doctor for individualised advice. For more information and support, see the Australian Medicines Handbook or call the NPS MedicineWise line at 1300 633 424.

Additional information

Dosage: No selection

1mg, 2mg

Package: No selection

10 pill, 30 pill, 60 pill, 90 pill, 120 pill, 180 pill, 360 pill